Multi-institutional study shows immune benefit when interleukin-2 is added to antirectroviral therap
University of California San Francisco
Give to UCSF
UC San Francisco researchers have discovered a region in the telomerase enzyme that they say could prove to be a target for killing cancer cells and regenerating damaged cells, and could also lead to a possible target for attacking HIV.